< Back

October, 2017

Evolving Market Dynamics Will Continue to Influence Use of Oncology Drugs by 2019

Brand Access Marketplace Dynamics    |    Research Released September 2017

Evolving Market Dynamics Will Continue to Influence Use of Oncology Drugs by 2019

Availability of new brands, emerging drug classes, and potential entrance of biosimilars may compel stakeholders to increase utilization management tactics, narrowing selection of preferred treatments.

Biopharmaceutical companies that support stakeholder objectives of achieving high-quality, cost-effective long-term care for oncology patients will benefit from improved relations and likely sustain optimal access for their brands.

Key Trends Driving Stakeholder Strategies to Influence Access to oncology drugs

Download the research slide

 

These and other findings can be found in Health Strategies Group’s recently released research Oncology Market Access Stakeholder Drug Management Outlook 2019.

Key topics included in this research: 

  • Evolution of oncology market
  • Future stakeholder management tactics for oncology products
    • Payers
    • Health systems
    • Oncology groups
  • Brand access predictions based on detailed scenarios
  • Evolving stakeholder contracting activities and influence on brand access

Download Research Agenda

 

Visit our Brand Access Marketplace Dynamics webpage to learn more about this research.

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.